Comparative Measurement of Spontaneous Apoptosis in Pediatric Acute Leukemia by Different Technniques

Cytometry Part B - Clinical Cytometry

Volumn 56, Issue 1, 2003, Pages 16-22

  Savitskiy, Valery P ^a   Shman, Tatiana V ^a   Potapnev, Michael P ^a  

^a Belarusian Research Center for Pediatric Oncology and Hematology   (Belarus)

Author keywords

Methods of detection; Pediatric acute leukemia; Spontaneous apoptosis

Indexed keywords

5,5',6,6' TETRACHLORO 1,1',3,3' TETRAETHYLBENZIMIDAZOLECARBOCYANINE IODIDE; ACRIDINE ORANGE; BENZIMIDAZOLE DERIVATIVE; BROXURIDINE; CARBOCYANINE; DNA FRAGMENT; ETHIDIUM BROMIDE; FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5; PHOSPHATIDYLSERINE; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; APOPTOSIS; ARTICLE; BONE MARROW BIOPSY; CANCER CELL CULTURE; CELL SUBPOPULATION; CHILD; CHILDHOOD LEUKEMIA; CHROMATIN CONDENSATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA DEGRADATION; DNA STRAND BREAKAGE; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; INFANT; INTERMETHOD COMPARISON; LEUKEMIA CELL; MAJOR CLINICAL STUDY; MALE; MEMBRANE POTENTIAL; METHODOLOGY; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STAINING;

ADOLESCENT; APOPTOSIS; B-LYMPHOCYTES; CELL LINEAGE; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; INFANT; LEUKEMIA, MYELOID, ACUTE; MALE; MEMBRANE POTENTIALS; MICROSCOPY, FLUORESCENCE; MITOCHONDRIA; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; STAINING AND LABELING; T-LYMPHOCYTES;

EID: 1442349834     PISSN: 15524949     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. DiGiuseppe JA, Kastan MB. Apoptosis in haematological malignancies. J Clin Pathol 1997;50:361-364.
2. Wuchter C, Karawajew L, Ruppert V, Schrappe M, Harbott J, Ratei R, Doeken B, Ludwig W-D. Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukemia. Br J Haematol 2000;110:154-160.
3. Garrido SM, Cooper JJ, Appelbaum FR, Willman CL, Kopecky K, Banker DE. Blasts from elderly acute myeloid leukemia patients are characterized by low level of culture- and drug-induced apoptosis. Leuk Res 2001;25:23-32.
4. Schuler D, Szende B. Apoptosis and acute lymphocytic leukemia in children. Ann NY Acad Sci 1997;824:28-37.
5. Blagosklonny MV. Cell death beyond apoptosis. Leukemia 2000;14:1502-1508.
6. Darzynkiewicz Z, Li X, Gong J, Traganos F. Methods for analysis of apoptosis by flow cytometry. In: Rose NR, de Macario EC, Folds JC, Lane HC, Nakamura RM, editors. Manual of clinical laboratory immunology, 5th edition. Washington, DC: ASM Press; 1997. p. 334-343.
7. Ormerod MG. The study of apoptotic cells by flow cytometry. Leukemia 1998;12;1013-1025.
8. Ricciardi MA, Petrucci MT, Gregorj C, Ariola C, Lemoli RM, Folgi M, Mauro R, Cerretti R, Foa R, Mandelli F, Tafuri A. Reduced susceptibility to apoptosis correlates with kinetic quiescence in disease progression of chronic lymphocytic leukemia. Br J Haematol 2001;113:391-399.
9. Lagneaux L, Delforge A, Carlier S, Massy M, Bernier M, Bron D. Early induction of apoptosis in B-chronic lymphocytic leukemia cells by hyroxychloroquine: activation of caspase-3 and no protection by survival factors. Br J Haematol 2001;112:344-352.
10. Rasola A, Geuna M. A flow cytometry assay simultaneously detects independent apoptotic parameters. Cytometry 2001;45:151-157.
11. Kawabata Y, Hirokawa M, Kitabayashi A, Horiuchi T, Kuroki J, Miura AB. Defective apoptotic signal transduction pathway downstream of caspase-3 in human B-lymphoma cells: a novel mechanism of nuclear apoptosis resistance. Blood 1999;94:3523-3530.
12. Salvioli S, Dobrucki J, Moretti L, Troiano L, Fernandez MG, Pinti M, Pedrazzi J, Franceschi C, Cossarizza A. Mitochondrial heterogeneity during staurosporine-induced apoptosis in HL-60 cells: analysis at the single cell and single organelle level. Cytometry 2000;40:189-197.
13. Pepper C, Thomas A, Tucker H, Hoy T, Bentley P. Flow cytometric assessment of three different methods for the measurement of in vitro apoptosis. Leuk Res 1998;22:439-444.
14. Bene MC, Castoldi G, Knapp W, Ludwig W-D, Matutes E, Orfao A, van't Veer MB. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 1995;9:1783-1786.
15. Dai J, Weinberg RS, Waxman S, Jing Y. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutatione redox system. Blood 1999;93:268-277.
16. Cossarizza A, Baccarani-Contri M, Kalashnikova G, Franceschi C. A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6′ -tetrachloro-1,1′,3,3′-tetraethyl-benzimidazolcarbocyanine iodide. Biochem Biophys Res Commun 1993;197:40-45.
17. Oliveira GB, Pereira FG, Metze K, Lorand-Metze I. Spontaneous apoptosis in chronic lymphocytic leukemia and its relationship to clinical and cell kinetic parameters. Cytometry 2001;46:329-335.
18. Roman V, Billard C, Kern C, Ferry-Dumazet H, Izard J-C, Mohammad R, Mossalayi DM, Kolb J-P. Analysis of resveratol-induced apoptosis in human B-cell chronic leukaemia. Br J Haematol 2002;117:842-851.
19. Efferth T, Fabry U, Osieka R. Apoptosis and resistance to daunorubicin in human leukemic cells. Leukemia 1997;11:1180-1186.
20. Rich IN, Worthington-White D, Garden OA, Musk P. Apoptosis of leukemic cells accompanies reduction in intracellular pH after targeted inhibition of the Na+/H+ exchanger. Blood 2000;95:1427-1434.
21. Soligo D, Servida F, Delia D, Fontanella E, Lamorte G, Caneva L, Fumiatti R, Deliliers GL. The apoptogenic response of human myeloid leukaemia cell lines and of normal and malignant haematopoietic progenitor cells to the proteasome inhibitor PSI. Br J Haematol 2001;113:126-135.
22. Smith BD, Bambach BJ, Vala MS, Barber JP, Enger C, Brodsky RA, Burke PJ, Gore SD, Jones PJ. Inhibited apoptosis and drug resistance in acute myeloid leukaemia. Br J Haematol 1998;102:1042-1049.
23. Wuchter C, Karawajew L, Ruppert V, Buchner T, Schoch C, Haferlanch T, Ratei R, Dorken B, Ludwig WD. Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in context of P-glycoprotein function, maturation stage, and cytogenetics. Leukemia 1999;13:1943-1953.
24. Banker DE, Groudine M, Norwood T, Appelbaum FR. Measurement of spontaneous and therapeutic agent-induced apoptosis with BCL-2 protein expression in acute myeloid leukemia. Blood 1997;89:243-255.
25. Span LFR, Pennings AHM, Vierwinden G, Boezeman JBM, Raymakers RAP, deWitte T. The dynamic process of apoptosis analyzed by flow cytometry using Annexin-V/propidium iodide and a modified in situ end labeling technique. Cytometry 2002;47:24-31.
26. Davies D. The assessment of apoptosis in drug-treated cells: an integrated approach to monitor time-related changes. In: Proceedings of ISAC XX Congress, Montpellier, France, May 20-25, 2000; Abstract 5600. Cytometry 2000;Suppl 10.